TY - JOUR
T1 - EBV infection of human B lymphocytes leads to down-regulation of bim expression
T2 - Relationship to resistance to apoptosis
AU - Clybouw, Cyril
AU - Mchichi, Bouchra
AU - Mouhamad, Shahul
AU - Auffredou, Marie Thérèse
AU - Bourgeade, Marie Françoise
AU - Sharma, Surendra
AU - Leca, Gerald
AU - Vazquez, Aimé
PY - 2005/9/1
Y1 - 2005/9/1
N2 - EBV infects a large proportion of the human population worldwide and is one of the major viruses with human B lymphocyte tropism. It can immortalize human B lymphocytes and controls their resistance to apoptosis. EBV infection is associated with several lymphomas, including Burkitt's lymphoma. In this report we show that EBV infection leads to the post-transcriptional down-regulation of expression of the proapoptotic protein Bim. This process involves the phosphorylation of BimEL by the constitutive EBV-activated kinase ERK1/2, followed by its degradation through the proteasome pathway. We also show that ectopic expression of BimEL in EBV-positive Burkitt's lymphoma cells can enhance the sensitivity of these cells to serum deprivation-dependent apoptosis. Thus, EBV-mediated resistance to growth factor deprivation in human B lymphocytes is dependent on BimEL expression. Our data suggest that this regulatory pathway is an important contributor to the oncogenic potential of EBV.
AB - EBV infects a large proportion of the human population worldwide and is one of the major viruses with human B lymphocyte tropism. It can immortalize human B lymphocytes and controls their resistance to apoptosis. EBV infection is associated with several lymphomas, including Burkitt's lymphoma. In this report we show that EBV infection leads to the post-transcriptional down-regulation of expression of the proapoptotic protein Bim. This process involves the phosphorylation of BimEL by the constitutive EBV-activated kinase ERK1/2, followed by its degradation through the proteasome pathway. We also show that ectopic expression of BimEL in EBV-positive Burkitt's lymphoma cells can enhance the sensitivity of these cells to serum deprivation-dependent apoptosis. Thus, EBV-mediated resistance to growth factor deprivation in human B lymphocytes is dependent on BimEL expression. Our data suggest that this regulatory pathway is an important contributor to the oncogenic potential of EBV.
UR - http://www.scopus.com/inward/record.url?scp=23844484177&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23844484177&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.175.5.2968
DO - 10.4049/jimmunol.175.5.2968
M3 - Article
C2 - 16116183
AN - SCOPUS:23844484177
SN - 0022-1767
VL - 175
SP - 2968
EP - 2973
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -